Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login
Journal of Cancer Research and Therapeutics, a publication of Association of Radiation Oncologists of India (AROI), is a peer-reviewed online journal with Quarterly print on demand compilation of issues published. The journalís full text is available online at http://www.cancerjournal.net. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository. The journal does not charge for submission, processing or publication of manuscripts and even for color reproduction of photographs.
CURRENT COVER
EDITORIAL BOARD

Editor in Chief
Dr. Nagraj Huilgol

Executive Editor
Rajiv Sarin, Mumbai, India

Associate Editor
Rakesh Jalali, Mumbai, India

View All Members

JCRT STATISTICS
  • 1,755 Total articles
  • 1,755 Full text articles
  • 277 Manuscripts submitted in '15
  • 79,398 Articles downloaded in 'March 2015

Special Issue

September 2013 Volume 9 | Issue 5 (Supplement)

Special Issue

November 2013 Volume 9 | Issue 7 (Supplement)

CURRENT ISSUE
December 2014| Vol 10| Issue 8 (Supplement)

Review Article

Updates in colorectal cancer stem cell research

Colorectal cancer (CRC) is one of the world most common malignant tumors, also is the main disease, which cause tumor-associated death. Surgery and chemotherapy are the most used treatment of CRC. Rec...


Review Article

Recent advances of histone modification in gastric cancer

Epigenetics play important roles during development progress of tumor. The histone modifications are the most important constituted field. Recently, accumulating research focused on exploring the role...


Review Article

High levels of D-dimer correlated with disease status and poor prognosis of inoperable metastatic colorectal cancer patients treated with bevacizumab

Purpose: To assess the levels of D-dimer baseline levels in inoperable metastatic colorectal cancer (mCRC) patients treated with bevacizumab and its relationship with prognosis. Materials ...


Original Article

MicroRNA-146a rs2910164 G/C polymorphism and gastrointestinal cancer susceptibility: A meta-analysis based on East Asian population

Objective: The relationship between microRNA (miR-146a) rs2910164G/C polymorphism and gastrointestinal cancer susceptibility is not consistent with each other of the published articles. The aim...


View All Articles